← FDA DRUG APPROVALS

FDA ANDA · ANDA080421

PROCAINE HYDROCHLORIDE

Sponsor: ABRAXIS PHARM

APPLICATION
ANDA080421
TYPE
ANDA
ORIGINAL APPROVAL
1972-12-08
LATEST ACTION
1972-12-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCAINE HYDROCHLORIDEDiscontinued
PROCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
PROCAINE HYDROCHLORIDEDiscontinued
PROCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

1972-12-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →